Researchers Work to Understand the Role of GDF15 in Lung Diseases Like Idiopathic Pulmonary Fibrosis

Growth differentiation factor 15 (GDF15) is expressed in normal conditions but is overly expressed when cells are under stress. It has multiple roles in different diseases and has been used…

Continue Reading Researchers Work to Understand the Role of GDF15 in Lung Diseases Like Idiopathic Pulmonary Fibrosis
Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
source: pixabay.com

Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease

  There are many common elements in Alzheimer’s disease (AD), which is the most common type of dementia. It is now evident that there are varied spans of disease progression…

Continue Reading Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA
source: pixabay.com

NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA

According to a press release from the rare liver disease company Albireo Pharma, Inc., the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for odevixibat.…

Continue Reading NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA
New Multiple Sclerosis Drug Rejected by NICE
https://pixabay.com/en/denied-insurance-rejected-stamp-1936877/

New Multiple Sclerosis Drug Rejected by NICE

The National Institute for Health and Clinical Excellence (NICE), an agency under the UK's National Health Service (NHS), has recently rejected Zeposia. Zeposia is an oral, multiple sclerosis (MS) treatment…

Continue Reading New Multiple Sclerosis Drug Rejected by NICE